Enter your login e-mail to the account
Search
Search parameters
Search results
- Lung cancer has crossed the threshold into the third millennium – part 1
MUDr. Anton Dzian, MUDr. Elena Kavcová, PhD., MUDr. Martina Ondrušová
(5/2010, Review articles )
- Autoimmune encephalitides
MUDr. David Krýsl, Ph.D.
(6/2015, Main topic )
- Inhibition ALK and ROS1 in the treatment of metastatic non-small lung cancer – new treatment options and recommendations
MUDr. Lucia Denková
(1/2021, Main topic ) - What’s new in immunotherapy for non-small cell lung cancer?
MUDr. Zuzana Pribulová
(1/2021, Main topic ) - The complications of lung cancer diagnostic process
MUDr. Radka Cahajlová, MUDr. Marián Marták
(6/2014, Original articles & case reports ) - Recent achievements in targeted treatment of advanced non-small cell lung cancer with rare RET, MET, BRAF and NTRK gene alterations
MUDr. Róbert Godál
(1/2021, Main topic ) - PHARMACOECONOMICAL EVALUATION OF ONCOLOGY DRUGS – DIFFICULTIES AND POSSIBLE SOLUTIONS
doc. MUDr. Ján Bielik, CSc., PharmDr. Dominikk Tomek, MPH
(1/2008, Review articles ) - News in the treatment of lung cancer
doc. MUDr. Peter Beržinec, CSc.
(4/2012, Review articles ) - Toracoscopic sublobary anatomic resections for secundary malignancies
Doc. MUDr. Miroslav Janík, PhD., MUDr. Martin Lučenič, PhD., MUDr. Peter Juhos, PhD., MUDr, Daniel Šiška, MUDr. Patrik Lauček, MUDr. Katarína Tarabová
(1/2021, Main topic ) - ACCES TO INNOVATIVE DRUGS IN ONCOLOGY IN SLOVAKIA – COMPARISON WITH THE WORLD
PharmDr. Dominik Tomek, MPH
(1/2008, Review articles ) - Treatment of EGFR- mutated non-small cell lung cancer – update
MUDr. Gabriela Chowaniecová, prof. MUDr. Dalibor Ondruš, DrSc.
(1/2021, Main topic ) - 13th Central European Lung Cancer Conference, Praha, 24. – 27. 6. 2012
doc. MUDr. Peter Beržinec, CSc.
(4/2012, Events ) - PHARMACOECONOMIC EVALUATION OF DOCETAXEL IN INDUCTION CHEMOTHERAPY OF LOCALLY ADVANCED SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK (SCCHN)
PharmDr. Dominik Tomek, MPH, MUDr. Milan jamárik
(1/2008, Review articles ) - Publikujeme v zahraničí
doc. MUDr. Michal Mego, PhD.
(4/2012, Information & comments ) - The pathologist´s contribution for a targeted biological therapy of neoplastic disorders
prof. MUDr. Lukáš Plank, CSc.
(1/2011, Review articles ) - The growth factors in oncology
MUDr. Ján Gyárfáš
(4/2012, Main topic ) - Targeted biological therapy for lung cancer – current status and perspectives
doc. MUDr. Peter Beržinec, CSc.
(1/2011, Review articles ) - Biological treatment of the small cell lung cancer
MUDr. Peter Kasan
(1/2007, Review articles ) - Lung cancer in elderly
doc. MUDr. Mária Wagnerová, CSc.
(1/2007, Review articles ) - 12th Central European Lung Cancer Conference
doc. MUDr. Peter Beržinec, CSc.
(1/2011, Events ) - Profile of atezolizumab in the treatment of lung cancer
MUDr. Zuzana Pribulová
(2/2024, Drugs & drug classes ) - 10. stredoeurópska konferencia o rakovine pľúc
doc. MUDr. Peter Beržinec, CSc.
(2/2006, Events ) - Pembrolizumab versus Chemotherapy for PD-L1–Positive Non-Small-Cell Lung Cancer
doc. MUDr. Peter Beržinec, CSc.
(5/2016, Information & comments ) - Clinical Cancer Advances 2010: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology
doc. MUDr. Peter Beržinec, CSc.
(1/2011, Information & comments ) - Správa zo zasadnutia Výboru Slovenskej onkologickej spoločnosti, 20. 12. 2010
Zapísal: doc. MUDr. Peter Beržinec, CSc.
(1/2011, Information & comments ) - Cisplatin and gemcitabine first-line chemotherapy followed by maintenance gemcitabine or best supportive care in advanced non-small cell lung cancer: a phase III trial
doc. MUDr. Peter Beržinec, CSc.
(3/2006, Information & comments ) - Surgical treatment of lung cancer
doc. MUDr. Roman Benej, PhD., prof. MUDr. Svetozár Haruštiak, CSc., MUDr. Miroslav Janík, MUDr. Tibor Krajč, MUDr. František Žernovický
(4/2007, Review articles ) - Optimal timing of chemotherapy and radiotherapy for stage III non-small cell lung cancer
doc. MUDr. Peter Beržinec, CSc., h. doc. MUDr. Elena Bolješíková, CSc.
(4/2007, Review articles ) - Chromosomal rearrangements in lung adenocarcinoma – new treatment options
RNDr. Katarína Hlinková
(3/2014, Review articles ) - Follow-up after treatment in patients with malignant disease
MUDr. Branislav Bystrický, MUDr. Filip Kohútek, MUDr. Andrej Rosík, MUDr. Miroslava Stratená, MUDr. Mário Bôžik
(3/2015, Main topic ) - Differential diagnostic considerations in medical care of a female patient with duplex malignant tumor
MUDr. Bibiána Krakovská
(4/2007, Original articles ) - Zaujímavosti z literatúry
doc. MUDr. Peter Beržinec, CSc.
(1/2009, Information & comments ) - Publikujeme v zahraničí
(6/2013, Information & comments ) - Molecular markers of targeted therapy in oncology malignancies
RNDr. Katarína Hlinková
(2/2010, Review articles ) - Managed hypertensive crisis induced by bevacizumab in patient with metastatic lung adenocarcinoma
MUDr. Klaudia Grácová, MUDr. Lucia Doláková
(6/2015, Main topic ) - How to improve the first line treatment of NSCLC with EGFR mutation?
doc. MUDr. Peter Beržinec, CSc.
(6/2016, Review articles ) - News in the immunotherapy of nonmetastatic non-small-cell lung cancer
MUDr. Lenka Medvecová
(1/2023, Main topic ) - Pneumotoxicity of molecularly targeted anticancer drugs
doc. MUDr. Peter Beržinec, CSc.
(1/2013, Main topic ) - Immune checkpoint inhibitors in non-small cell lung cancer therapy
MUDr. Mária Černá, CSc.
(6/2015, Main topic ) - Treatment of ALK-rearranged non-small cell lung cancer
MUDr. Zuzana Pribulová
(6/2015, Main topic ) - Horizontal scanning and fast scanning system of anticancer treatment in Slovakia. The first results of the pilot project
PharmDr. Dominik Tomek, PhD., MPH1, prof. MUDr. Jozef Holomáň, CSc., MVDr. Peter Mrva, MPH
(2/2017, Main topic ) - Správa z Best of ASCO® Slovakia 2015
MUDr. Mária Rečková
(6/2015, Events ) - Clinical significance of PD-L1 immune check-point measurement
MUDr. Peter Kasan
(2/2017, Drugs & drug classes ) - Publikujeme v zahraničí
(2/2017, Information & comments ) - Cancer drug consumption in Slovakia and its economic impact – development and trends
prof. RNDr. Viliam Foltán, CSc., PharmDr. Veronika Dubajová, Mgr. Katarína Gatialová , Mgr. Katarína Bellová
(3/2011, Review articles ) - Zaujímavosti z literatúry: Analýzy biomarkerov a definitívne výsledky celkového prežitia z randomizovanej, otvorenej, prvolíniovej štúdie gefitinib verzus karboplatina/paklitaxel u klinicky vybraných pacientov s pokročilým nemalobunkovým karcinómom pľúc v
Editor rubriky: doc. MUDr. Peter Beržinec, CSc.
(3/2011, Information & comments ) - Zaujímavosti z literatúry
doc. MUDr. Peter Beržinec, CSc.
(6/2009, Information & comments ) - The characteristics of lung cancer in young adults
MUDr. Peter Kasan, MUDr. Mária Černá, CSc., MUDr. Radka Cahajlová, MUDr. Marián Marták, MUDr. Milada Veselá, MUDr. Lucia Denková, MUDr. Zuzana Šviheľová-Lišková
(3/2016, Original articles & case reports ) - Treatment of advanced metastatic lung cancer in older patients
doc. MUDr. Peter Beržinec, CSc.
(5/2012, Main topic ) - Aktuálne možnosti diagnostiky a liečby pacientov s ALK+ NSCLC
Kolektív autorov
(S4/2020, Main topic ) - Data back Merck’s Keytruda for first-line NSCLC
doc. MUDr. Peter Beržinec, CSc.
(3/2016, Information & comments ) - 14. svetová konferencia o karcinóme pľúc v Amsterdame
doc. MUDr. Peter Beržinec, CSc.
(5/2011, Events ) - Publikujeme v zahraničí
(5/2011, Information & comments ) - Do we know the number of lung cancer patients in Slovakia?
doc. RNDr. PhDr. Martina Ondrušová, PhD., MPH, Ing. Martin Suchanský, MUDr. Bela Mriňáková, PhD., MPH, MHA, MUDr. Michal Urda
(4/2023, Original articles ) - Carcinoid Tumors
MUDr. Jaroslava Barkmanová
(3/2010, Review articles ) - The turbulent evolution of treatment strategies for early-diagnosed NSCLC
MUDr. Gabriela Chowaniecová, PhD., prof. MUDr. Dalibor Ondruš, DrSc.
(S2/2023, Review articles ) - Report from the 1st Abbott Conference for Cancer Nutrition Therapy, April 12-14, 2010, Istanbul Turkey
MUDr. Peter Vaněk
(3/2010, Events ) - First guidelines for oligometastatic non-small cell lung cancer and radiotherapy
MUDr. Karol Martinka
(S2/2023, Review articles ) - News in the treatment of non-small cell lung cancer in the first half of 2023 in the world and new therapies in Slovakia
MUDr. Dominik Šafčák, PhD., MPH
(S2/2023, Review articles ) - Consensus of the multidisciplinary working group on organisational changes in the care of patients with early diagnosed non-small cell lung cancer
MUDr. Milada Veselá, MUDr. Lucia Denková, Doc. MUDr. Anton Dzian, PhD., MUDr. Roman Klimčík, MUDr. Jana Jankurová, MUDr. Peter Juhos, PhD., MUDr. Gabriela Chowaniecová, PhD., MUDr. Štefan Laššán, PhD., MPH, MUDr. Peter Palúch, MUDr. Zuzana Pribulová, MUDr. Michal Urda, PhD.
(S2/2023, Review articles ) - Current possibilities of immunotherapy in non-small cell lung cancer
doc. MUDr. Peter Beržinec, CSc.
(3/2020, Review articles ) - Why do some lung cancer patients receive no anticancer treatment?
doc. MUDr. Peter Beržinec, CSc.
(5/2010, Information & comments ) - Osteoblastic flare effect during targeted therapy in lung adenocarcinoma
MUDr. Gabriela Chowaniecová
(4/2013, Original articles & case reports ) - Pokrok v imunoterapii malígneho melanómu a karcinómu pľúc inhibítormi imunitných kontrolných bodov
MUDr. Róbert Godál
(2/2018, Main topic ) - Nežiaduce účinky imunoterapie a ich manažment
MUDr. Jaroslava Lešková
(2/2018, Main topic ) - Publikujeme v zahraničí
(4/2013, Information & comments ) - Zaujímavosti zo zahraničnej literatúry
Doc. MUDr. Peter Beržinec, CSc.
(2/2018, Information & comments ) - Annual Report on Progress Against Cancer From the American Society of Clinical Oncology
doc. MUDr. Peter Beržinec, CSc.
(1/2015, Information & comments ) - Current indications for pemetrexed in the treatment of non-small cell lung cancer
doc. MUDr. Peter Beržinec, CSc.
(4/2009, Review articles ) - Publikujeme v zahraničí
redakcia
(3/2018, Information & comments ) - Odporúčania Slovenskej onkologickej spoločnosti SLS pre použitie bisfosfonátov v liečbe solídnych nádorov
prof. MUDr. Stanislav Špánik, CSc.
(4/2009, Recommendations ) - Chemotherapy of lung cancer – what is new in 2009?
doc. MUDr. Peter Beržinec, CSc.
(1/2010, Review articles ) - Zaujímavosti z literatúry
doc. MUDr. Peter Beržinec, CSc.
(4/2009, Information & comments ) - A new trend in targeted (biologic) therapy of non-small cell lung cancer in the 2009 – maintenance therapy
MUDr. Peter Kasan
(1/2010, Review articles ) - The treatment of ALK-positive NSCLC ceritinib – view panel of experts Purpose: To find out the opinion of the Panel of experts on the effectiveness and
doc. MUDr. Peter Beržinec, CSc., MUDr. Peter Kasan
(6/2015, Information & comments ) - The role of radiotherapy in lung cancer
MUDr. Elena Bolješíková, CSc.
(1/2010, Review articles ) - Lung cancer molecular testing in Slovak Republic – view clinical practise
doc. MUDr. Peter Beržinec, CSc., MUDr. Peter Kasan, MUDr. Andrea Cipková, MPH., MUDr. Mária Černá, CSc., MUDr. Róbert Godál, MUDr. Gabriela Chowaniecová, MUDr. Igor Andrašina, CSc.
(6/2015, Main topic ) - XIII. Košické chemoterapeutické dni
MUDr. Valér Kováč, PhD.
(1/2010, Events ) - WHAT ARE WE ABLE TO ACHIEVE IN THE TREATMENT OF METASTATIC NON-SMALL CELL LUNG CANCER TODAY?
doc. MUDr. Peter Beržinec, CSc.
(3/2008, Original articles ) - Skin toxicity of EGFR inhibitors
MUDr. Katarína Poláková, PhD.
(6/2016, Review articles ) - Immunotherapy for lung cancer
doc. MUDr. Peter Beržinec, CSc.
(4/2016, Main topic ) - 11 11TH TH CENTRAL EUROPEAN LUNG CANCER CONFERENCE
doc. MUDr. Peter Beržinec, CSc.
(3/2008, Events ) - Rare lung cancers
doc. MUDr. Peter Beržinec, CSc.
(2/2013, Main topic ) - Palliative radiotherapy – brain metastatic disease
MUDr. Elena Bolješíková, CSc., MUDr. Martin Chorváth
(5/2013, Main topic ) - Stereotactic radiotherapy lung cancer
MUDr. Iveta Priatelová, MUDr. Natália Janíčková, MUDr. Marek Marinčák
(5/2013, Main topic ) - Treatment of inicially metastatic small-cell lung cancer
MUDr. Branislav Bystrický, MUDr. Filip Kohútek, doc. MUDr. Mária Tamášová, CSc.
(5/2013, Review articles ) - Správa z podujatia ASCO Chicago 2012
(3/2012, Events ) - Publikujeme v zahraničí
(2/2013, Information & comments ) - Zaujímavosti zo zahraničnej literatúry
doc. MUDr. Peter Beržinec, CSc.
(2/2013, Information & comments ) - Non small-cell lung cancer and treatment options after tyrosine kinase inhibitors failure in the first line
MUDr. Gabriela Chowaniecová
(5/2014, Original articles & case reports ) - Správa z Best of ASCO® Slovakia 2016
MUDr. Mária Rečková
(4/2016, Events ) - Radiotherapy of inoperable, locally advanced non-small cell lung cancer
MUDr. Iveta Priatelová, Ing. Miroslav Olejár
(2/2023, Main topic ) - Správa z IX. bardejovských onkologických dní
doc. MUDr. Mária Wagnerová, CSc.
(4/2016, Events ) - Dual EGFR mutation in patient with non-small cell lung cancer
MUDr. Martin Horný, MUDr. Lucia Doláková, MUDr. Kristína Šuhajdová, MUDr. Klaudia Grácová
(2/2023, Main topic ) - Advances in the systemic treatment of non-small cell lung cancer
MUDr. Mária Černá, CSc.
(2/2023, Main topic ) - Surgery for non-small cell lung cancer – current trends
Doc. MUDr. Anton Dzian, PhD., MUDr. Marek Malík, PhD.
(2/2023, Main topic ) - Crizotinib – a new molecule in the treatment of lung cancer?
MUDr. Lenka Medvecová
(1/2012, Drugs & drug classes ) - Rádiologický CT staging karcinómu pľúc
MUDr. René Hako
(5/2013, Information & comments ) - Správa z Best of ASCO® Slovakia 2011
MUDr. Mária Rečková
(1/2012, Events ) - 12 12TH TH WORLD CONFERENCE ON LUNG CANCER, WORLD CONFERENCE ON LUNG CANCER,
doc. MUDr. Peter Beržinec, CSc.
(5/2007, Events ) - Úvodné slovo
MUDr. Radovan Barilla, PhD.
(1/2012, Editorial ) - Publikujeme v zahraničí
(5/2015, Information & comments ) - Publikujeme v zahraničí
(1/2016, Information & comments ) - Monoclonal antibodies in antitumorous therapy and infectious complications
MUDr. Ľuboš Drgoňa, CSc.
(6/2010, Review articles ) - Pembrolizumab for the treatment of non-small-cell lung cancer
doc. MUDr. Peter Beržinec, CSc.
(2/2015, Information & comments ) - ESMO 2010 – kongres, ktorý prelomil rekordy
doc. MUDr. Peter Beržinec, CSc.
(6/2010, Events ) - The role of biomarkers in cardiotoxicity detection in childhood cancer survivors
doc. MUDr. Beáta Mladosievičová, CSc., MUDr. Dagmar Urbanová
(4/2010, Original articles & case reports ) - Zaujímavosti z literatúry - ESMO usmernenia pre klinickú prax: príprava, realizácia a šírenie. Editoriál
doc. MUDr. Peter Beržinec, CSc.
(4/2010, Information & comments ) - Best of ASCO Slovakia 2010
MUDr. Mária Rečková
(6/2010, Events ) - Zaujímavosti z literatúry - Stratégie pre predĺženú liečbu u pacientov s pokročilým nemalobunkovým karcinómom pľúc
doc. MUDr. Peter Beržinec, CSc.
(6/2010, Information & comments ) - Novinky z American Society of Clinical Oncology 2010
doc. MUDr. Peter Beržinec, CSc., MUDr. Tomáš Šálek, prof. MUDr. Stanislav Špánik, CSc., MUDr. Mária Rečková
(4/2010, Events ) - VI. Bardejovské onkologické dni
MUDr. Jozef Chovanec
(4/2010, Events ) - Správa z Best of ASCO® Slovakia 2012
MUDr. Mária Rečková
(6/2012, Events ) - 17. svetová konferencia o karcinóme pľúc
Doc. MUDr. Peter Beržinec, CSc.
(1/2017, Events ) - Publikujeme v zahraničí
(1/2017, Information & comments ) - Zaujímavosti zo zahraničnej literatúry
doc. MUDr. Peter Beržinec, CSc.
(2/2014, Information & comments ) - The use of 18F-FDG PET/CT for radiotherapy planning
MUDr. Andrea Masaryková
(2/2016, Main topic ) - SHOX2 gene methylation as a diagnostic marker of lung cancer
RNDr. Michal Konečný, PhD., Mgr. Lenka Dolešová, doc. RNDr. Iveta Waczulíková, PhD., doc. MUDr. Ivan Majer, CSc., Mgr. Ján Markus, PhD.1, MUDr. Helena Novosadová
(2/2016, Original articles & case reports ) - Nintendanib – new triple inhibitor of angiokinases in 2nd line of NSCLC
MUDr. Zuzana Pribulová
(2/2016, Drugs & drug classes ) - Novinky v onkológii
MUDr. Tomáš Šálek
(1/2018, Information & comments ) - CURRENT TRENDS OF THE EXTERNAL RADIOTHERAPY IN TREATMENT OF NON SMALL-CELL LUNG CANCER
MUDr. Richard Hrubý, PhD.
(3/2006, Review articles ) - News in the treatment of lung tumors in the elderly
MUDr. Zuzana Pribulová
(6/2023, Main topic ) - 2011 Focused Update of 2009 American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancer
Editor rubriky: doc. MUDr. Peter Beržinec, CSc.
(6/2011, Information & comments )
- Acne-like rash and another skin toxicities associated with administration of HER1/EGFR inhibitors
MUDr. Katarína Poláková, PhD.
(1/2010, Review articles )